NCT02852265View on ClinicalTrials.gov

Nexplanon and Combined Oral Contraceptive (COC) Combined Use Study

PHASE4CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

September 15, 2016

Primary Completion Date

July 26, 2017

Study Completion Date

July 26, 2017

Conditions
Contraception
Interventions
DRUG

Etonogestrel contraceptive implant

Place nexplanon

Trial Locations (1)

95817

University of California, Davis, Sacramento

All Listed Sponsors
collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

University of California, Davis

OTHER

NCT02852265 - Nexplanon and Combined Oral Contraceptive (COC) Combined Use Study | Biotech Hunter | Biotech Hunter